4.6 Article

Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice

期刊

PLOS ONE
卷 11, 期 2, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0150236

关键词

-

资金

  1. Dutch Heart Foundation [2009B025, 2012T094]
  2. Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation
  3. Dutch Federation of University Medical Centers
  4. Netherlands Organization for Health Research and Development (ZonMW)
  5. Royal Netherlands Academy of Sciences (CVON-ARENA)
  6. Netherlands Organization for Scientific Research (NWO) [Vidi 91714363]
  7. European Union Commission [261409]
  8. European Research Council [311549]
  9. Ministry of Education, Science, Sports, and Culture of Japan (MEXT) [26113005]
  10. National Institutes of Health [GM088252]
  11. American Cancer Society [RSG-11-174-01-RMC]
  12. European Research Council (ERC) [311549] Funding Source: European Research Council (ERC)
  13. Grants-in-Aid for Scientific Research [15K21720, 26113005] Funding Source: KAKEN

向作者/读者索取更多资源

Background Long non-coding RNAs (lncRNAs) are a class of RNA molecules with diverse regulatory functions during embryonic development, normal life, and disease in higher organisms. However, research on the role of lncRNAs in cardiovascular diseases and in particular heart failure is still in its infancy. The exceptionally well conserved nuclear lncRNA Metastasis associated in lung adenocarcinoma transcript 1 (Malat-1) is a regulator of mRNA splicing and highly expressed in the heart. Malat-1 modulates hypoxia-induced vessel growth, activates ERK/MAPK signaling, and scavenges the anti-hypertrophic microRNA-133. We therefore hypothesized that Malat-1 may act as regulator of cardiac hypertrophy and failure during cardiac pressure overload induced by thoracic aortic constriction (TAC) in mice. Results Absence of Malat-1 did not affect cardiac hypertrophy upon pressure overload: Heart weight to tibia length ratio significantly increased in WT mice (sham: 5.78 +/- 0.55, TAC 9.79 +/- 1.82 g/mm; p<0.001) but to a similar extend also in Malat-1 knockout (KO) mice (sham: 6.21 +/- 1.12, TAC 8.91 +/- 1.74 g/mm; p<0.01) with no significant difference between genotypes. As expected, TAC significantly reduced left ventricular fractional shortening in WT (sham: 38.81 +/- 6.53%, TAC: 23.14 +/- 11.99%; p<0.01) but to a comparable degree also in KO mice (sham: 37.01 +/- 4.19%, TAC: 25.98 +/- 9.75%; p<0.05). Histological hallmarks of myocardial remodeling, such as cardiomyocyte hypertrophy, increased interstitial fibrosis, reduced capillary density, and immune cell infiltration, did not differ significantly between WT and KO mice after TAC. In line, the absence of Malat-1 did not significantly affect angiotensin II-induced cardiac hypertrophy, dysfunction, and overall remodeling. Above that, pressure overload by TAC significantly induced mRNA levels of the hypertrophy marker genes Nppa, Nppb and Acta1, to a similar extend in both genotypes. Alternative splicing of Ndrg2 after TAC was apparent in WT (isoform ratio; sham: 2.97 +/- 0.26, TAC 1.57 +/- 0.40; p<0.0001) and KO mice (sham: 3.64 +/- 0.37; TAC: 2.24 +/- 0.76; p<0.0001) and interestingly differed between genotypes both at baseline and after pressure overload (p<0.05 each). Conclusion These findings confirm a role for the lncRNA Malat-1 in mRNA splicing. However, no critical role for Malat-1 was found in pressure overload-induced heart failure in mice, despite its reported role in vascularization, ERK/MAPK signaling, and regulation of miR-133.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction

Elisa Dal Canto, Sharon Remmelzwaal, Adriana Johanne van Ballegooijen, M. Louis Handoko, Stephane Heymans, Vanessa van Empel, Walter J. Paulus, Giel Nijpels, Petra Elders, Joline W. J. Beulens

Summary: This study evaluated the diagnostic performance of echocardiographic markers for HFpEF and LVDD, finding that a multivariable model showed the highest diagnostic performance, left atrial strain had reasonable performance, and adding exercise E/e ' improved the sensitivity of HFpEF diagnostic algorithms. Larger, well-designed studies are needed to further evaluate the potential diagnostic role of novel tools in current diagnostic algorithms.

HEART FAILURE REVIEWS (2022)

Article Multidisciplinary Sciences

Sex differences in the longitudinal relationship of low-grade inflammation and echocardiographic measures in the Hoorn and FLEMENGHO Study

Sharon Remmelzwaal, Joline W. J. Beulens, Petra J. M. Elders, Coen D. A. Stehouwer, Zhenyu Zhang, M. Louis Handoko, Yolande Appelman, Vanessa van Empel, Stephane R. B. Heymans, Lutgarde Thijs, Jan A. Staessen, A. Johanne van Ballegooijen

Summary: This study did not show consistent associations between LGI and ED with echocardiographic measures. Some evidence of effect modification by sex was present for ED and specific biomarkers.

PLOS ONE (2021)

Article Cardiac & Cardiovascular Systems

Parvovirus B19 DNA detectable in hearts of patients with dilated cardiomyopathy, but absent or inactive in blood

Anne Russcher, Job Verdonschot, Marijke W. A. Molenaar-de Backer, Stephane R. B. Heymans, Aloys C. M. Kroes, Hans L. Zaaijer

Summary: This study suggests that B19V DNA in the blood of DCM patients becomes undetectable or greatly reduced after treatment with endonuclease, whereas DNA in the blood of recent B19V infections remains unaffected. This indicates that circulating viral DNA in DCM patients with presumed parvovirus-associated DCM does not consist of intact viral particles.

ESC HEART FAILURE (2021)

Article Virology

Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development

Monika Z. Ballmann, Svjetlana Raus, Ruben Engelhart, Gyozo L. Kajan, Abdelaziz Beqqali, Patrick W. F. Hadoke, Chantal van der Zalm, Tibor Papp, Lijo John, Selina Khan, Satish Boedhoe, Katarina Danskog, Lars Frangsmyr, Jerome Custers, Wilfried A. M. Bakker, Hilde M. van der Schaar, Niklas Arnberg, Angelique A. C. Lemckert, Menzo Havenga, Andrew H. Baker

Summary: The study introduces a chimeric human adenovirus, HAdV-20-42-42, which shows promise in gene therapy and vaccine development. It is capable of stable propagation, transducing cardiovascular cells effectively, and inducing potent T-cell responses. This novel vector expands the toolbox for vaccine development, providing valuable additions to the field.

JOURNAL OF VIROLOGY (2021)

Article Cardiac & Cardiovascular Systems

Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)

Rudolf A. de Boer, Stephane Heymans, Johannes Backs, Lucie Carrier, Andrew J. S. Coats, Stefanie Dimmeler, Thomas Eschenhagen, Gerasimos Filippatos, Lior Gepstein, Jean-Sebastien Hulot, Ralph Knoll, Christian Kupatt, Wolfgang A. Linke, Christine E. Seidman, C. Gabriele Tocchetti, Jolanda van der Velden, Roddy Walsh, Petar M. Seferovic, Thomas Thum

Summary: This article discusses the pathogenesis, clinical presentation, and new medications and therapeutic approaches for genetic cardiomyopathies. With the use of contemporary research methods and tools, our understanding of cardiomyopathies has deepened, opening up new avenues for precision medicine.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

Theresa A. McDonagh, Marco Metra, Marianna Adamo, Roy S. Gardner, Andreas Baumbach, Michael Boehm, Haran Burri, Javed Butler, Jelena Celutkien, Ovidiu Chioncel, John G. F. Cleland, Andrew J. S. Coats, Maria G. Crespo-Leiro, Dimitrios Farmakis, Martine Gilard, Stephane Heymans, Arno W. Hoes, Tiny Jaarsma, Ewa A. Jankowska, Mitja Lainscak, Carolyn S. P. Lam, Alexander R. Lyon, John J. McMurray, Alexandre Mebazaa, Richard Mindham, Claudio Muneretto, Massimo Francesco Piepoli, Susanna Price, Giuseppe M. C. Rosano, Frank Ruschitzka, Anne Kathrine Skibelund

Summary: All experts involved in the development of the guidelines have declared their interests, and the declarations have been compiled and published in a supplementary report. The report can be accessed on the ESC website. The supplementary data provide background information and detailed discussion of the data that form the basis for the guidelines.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial

Susana Ravassa, Begona Lopez, Joao Pedro Ferreira, Nicolas Girerd, Erwan Bozec, Pierpaolo Pellicori, Beatrice Mariottoni, Franco Cosmi, Mark Hazebroek, Job A. J. Verdonschot, Joe Cuthbert, Johannes Petutschnigg, Maria U. Moreno, Stephane Heymans, Jan A. Staessen, Burkert Pieske, Frank Edelmann, Andrew L. Clark, John G. F. Cleland, Faiez Zannad, Javier Diez, Arantxa Gonzalez

Summary: The HOMAGE randomized trial showed that spironolactone reduced left atrial volume index (LAVI), E:A ratio, and a marker of collagen synthesis in patients at risk of heart failure. Patients with low serum collagen cross-linking benefited more from spironolactone treatment on left atrial remodeling and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications

Elmir Omerovic, Rodolfo Citro, Eduardo Bossone, Bjorn Redfors, Johannes Backs, Bastian Bruns, Michele Ciccarelli, Liam S. Couch, Dana Dawson, Guido Grassi, Massimo Iacoviello, Guido Parodi, Birke Schneider, Christian Templin, Jelena R. Ghadri, Thomas Thum, Ovidiu Chioncel, C. Gabriele Tocchetti, Jolanda van der Velden, Stephane Heymans, Alexander R. Lyon

Summary: The scientific statement on the pathophysiology of Takotsubo syndrome discusses various aspects including catecholamines, the sympathetic nervous system, vascular responses, the role of the nervous systems, gender differences, sex hormones, genetics, and chronic abnormalities of cardiovascular physiology in survivors. The limitations of current clinical and preclinical studies, implications for clinical management, and future research perspectives are also highlighted.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology

Massimo F. Piepoli, Marianna Adamo, Andrea Barison, Reinaldo B. Bestetti, Jan Biegus, Michael Boehm, Javed Butler, Jonathan Carapetis, Claudio Ceconi, Ovidiu Chioncel, Andrew Coats, Maria G. Crespo-Leiro, Giovanni de Simone, Heinz Drexel, Michele Emdin, Dimitros Farmakis, Martin Halle, Stephane Heymans, Tiny Jaarsma, Ewa Jankowska, Mitja Lainscak, Carolyn S. P. Lam, Maja-Lisa Lochen, Yuri Lopatin, Aldo Maggioni, Benedetta Matrone, Marco Metra, Katharine Noonan, Ileana Pina, Eva Prescott, Giuseppe Rosano, Petar M. Seferovic, Karen Sliwa, Simon Stewart, Alicia Uijl, Ilonca Vaartjes, Roel Vermeulen, W. M. Monique Verschuren, Maurizio Volterrani, Stephan von Haehling, Arno Hoes

Summary: This article discusses the growing epidemic of heart failure and the importance of prevention in reducing hospital readmission rates and its clinical and economic burden. It aims to provide evidence-based information and effective preventive measures. By analyzing risk factors and population attributable risks in different continents, potential opportunities for prevention and strategies are identified. The article also lists potential interventions that have been shown to be effective in preventing heart failure.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial

Job A. J. Verdonschot, JoAo Pedro Ferreira, Anne Pizard, Pierpaolo Pellicori, Hans-Peter Brunner La Rocca, Andrew L. Clark, Franco Cosmi, Joe Cuthbert, Nicolas Girerd, Olivia J. Waring, Michiel H. T. M. Henkens, Beatrice Mariottoni, Johannes Petutschnigg, Patrick Rossignol, Mark R. Hazebroek, John G. F. Cleland, Faiez Zannad, Stephane R. B. Heymans

Summary: This study aimed to evaluate the effects of spironolactone and the characteristics of biomarkers associated with obesity. Proteomic analysis revealed a distinct biomarker profile in obese patients, reflecting adipogenesis and glucose intolerance. Additionally, obesity significantly modified the effect of spironolactone on systolic blood pressure.

JOURNAL OF CARDIAC FAILURE (2022)

Editorial Material Cardiac & Cardiovascular Systems

Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms

Stephane Heymans, Leslie T. Cooper

Summary: The risk of acute myocarditis associated with COVID-19 mRNA vaccination is rare and usually resolves quickly, while the risks of hospitalization and death from COVID-19 are greater. Therefore, COVID-19 vaccination is recommended for adolescents and adults.

NATURE REVIEWS CARDIOLOGY (2022)

Editorial Material Genetics & Heredity

Editorial: RNA Biology in Cardiovascular Disease

Maarten M. G. van den Hoogenhof, Hamid El Azzouzi, Abdelaziz Beqqali

FRONTIERS IN GENETICS (2021)

Article Cardiac & Cardiovascular Systems

Mapping the developing human cardiac endothelium at single-cell resolution identifies MECOM as a regulator of arteriovenous gene expression

Ian R. McCracken, Ross Dobie, Matthew Bennett, Rainha Passi, Abdelaziz Beqqali, Neil C. Henderson, Joanne C. Mountford, Paul R. Riley, Chris P. Ponting, Nicola Smart, Mairi Brittan, Andrew H. Baker

Summary: The study aims to characterize the transcriptome of human foetal cardiac endothelium using single-cell RNA sequencing (scRNA-seq) to provide insights into cellular heterogeneity and transcriptional dynamics underlying endothelial specification. Results reveal distinct endothelial cell populations, endocardial contribution to coronary vasculature, and arterial specification of capillary endothelium. Transcriptional signatures defining endothelial subpopulations are largely conserved between human and mouse, with MECOM playing a role in maintaining arterial endothelial identity.

CARDIOVASCULAR RESEARCH (2022)

Article Cardiac & Cardiovascular Systems

Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis

Paolo Carai, Anna Pia Papageorgiou, Sophie Van Linthout, Sophie Deckx, Sebastiaan Velthuis, Esther Lutgens, Erwin Wijnands, Carsten Tschoepe, Christina Schmuttermaier, Julia Kzhyshkowska, Elizabeth Anne Vincent Jones, Stephane Heymans

Summary: This study reveals the immune-suppressive role of stabilin-1 in limiting myocardial damage during viral myocarditis, by regulating the recruitment of anti-inflammatory monocytes to the site of inflammation.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Human embryonic stem cell-derived endothelial cell product injection attenuates cardiac remodeling in myocardial infarction

Ana-Mishel Spiroski, Ian R. McCracken, Adrian Thomson, Marlene Magalhaes-Pinto, Mukesh K. Lalwani, Kathryn J. Newton, Eileen Miller, Cecile Benezech, Patrick Hadoke, Mairi Brittan, Joanne C. Mountford, Abdelaziz Beqqali, Gillian A. Gray, Andrew H. Baker

Summary: This study investigated the tissue remodeling effects of human embryonic stem cell-derived endothelial cell product (hESC-ECP) therapy on infarcted heart and found that it reduces infarct size and preserves functional myocardium. By examining the interactions between cells and immune regulation, this research provides new therapeutic avenues for improving cardiac outcomes following myocardial infarction.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

暂无数据